CC
ARNA

Cedar Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cedar Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,650
Closed -$24K – 120
2017
Q1 		$24K Hold
1,650
– – 0.01% 99
2016
Q4 		$23K Hold
1,650
– – 0.01% 86
2016
Q3 		$29K Hold
1,650
– – 0.01% 92
2016
Q2 		$28K Hold
1,650
– – 0.01% 81
2016
Q1 		$33K Hold
1,650
– – 0.01% 69
2015
Q4 		$31K Buy
+1,650
New +$33.7K 0.01% 75

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cedar Capital's ARNA Position: Q2 2017 in Review

Cedar Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 1,650 shares — an estimated $24K sold.

Cedar Capital first reported a position in ARNA in Q4 2015 and held it in 6 quarters. The position peaked at $33K in Q1 2016. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Cedar Capital reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Cedar Capital sold 1,650 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $24K.
  • Cedar Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 6 quarters.
  • Cedar Capital's Arena Pharmaceuticals Inc position peaked at $33K in Q1 2016.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Cedar Capital's 13F filing for Q2 2017, filed 9 Aug 2017.